Schedule 13G ownership disclosure

INFINITY PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 45665G303

Event date: 2021-01-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,368,500
Percent of class
6.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-21-000060
Form type
SC 13G
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
Jan 26, 2021
Reporting period
Jan 22, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub